The article provides a detailed analysis of analyst ratings for Inari Medical, showing a mix of bullish and neutral sentiments. The average price target has increased slightly, indicating a generally positive outlook. However, the company's financials reveal challenges in profitability and asset utilization, which may offset the positive revenue growth. This mixed information suggests a neutral short-term impact on the stock price.